Structure

Physi-Chem Properties

Molecular Weight:  562.22
Volume:  532.997
LogP:  0.165
LogD:  0.676
LogS:  -2.358
# Rotatable Bonds:  8
TPSA:  187.48
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.211
Synthetic Accessibility Score:  5.238
Fsp3:  0.556
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.043
MDCK Permeability:  4.72107385576237e-05
Pgp-inhibitor:  0.016
Pgp-substrate:  0.995
Human Intestinal Absorption (HIA):  0.888
20% Bioavailability (F20%):  0.016
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.241
Plasma Protein Binding (PPB):  36.956817626953125%
Volume Distribution (VD):  0.416
Pgp-substrate:  53.44807052612305%

ADMET: Metabolism

CYP1A2-inhibitor:  0.006
CYP1A2-substrate:  0.105
CYP2C19-inhibitor:  0.021
CYP2C19-substrate:  0.591
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.042
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.092
CYP3A4-inhibitor:  0.02
CYP3A4-substrate:  0.245

ADMET: Excretion

Clearance (CL):  0.939
Half-life (T1/2):  0.384

ADMET: Toxicity

hERG Blockers:  0.094
Human Hepatotoxicity (H-HT):  0.39
Drug-inuced Liver Injury (DILI):  0.788
AMES Toxicity:  0.436
Rat Oral Acute Toxicity:  0.182
Maximum Recommended Daily Dose:  0.88
Skin Sensitization:  0.099
Carcinogencity:  0.91
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.697

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC291759

Natural Product ID:  NPC291759
Common Name*:   Paratunamide A
IUPAC Name:   (3S,4R,4aS,6R)-4-ethenyl-7-[2-[(3S)-3-hydroxy-2-oxo-1H-indol-3-yl]ethyl]-6-methoxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyridin-8-one
Synonyms:  
Standard InCHIKey:  XEQPPTNZKGNKKE-OVINQPFISA-N
Standard InCHI:  InChI=1S/C27H34N2O11/c1-3-13-14-10-19(37-2)29(9-8-27(36)16-6-4-5-7-17(16)28-26(27)35)23(34)15(14)12-38-24(13)40-25-22(33)21(32)20(31)18(11-30)39-25/h3-7,12-14,18-22,24-25,30-33,36H,1,8-11H2,2H3,(H,28,35)/t13-,14+,18-,19-,20-,21+,22-,24+,25+,27+/m1/s1
SMILES:  CO[C@@H]1C[C@H]2[C@@H](C=C)[C@@H](OC=C2C(=O)N1CC[C@@]1(O)C(=Nc2c1cccc2)O)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL504945
PubChem CID:   16091680
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0002207] O-glycosyl compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18036 Cinnamodendron axillare Species Canellaceae Eukaryota n.a. n.a. n.a. PMID[17067176]
NPO18036 Cinnamodendron axillare Species Canellaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 > 10.0 ug.mL-1 PMID[487381]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC291759 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9939 High Similarity NPC133591
0.976 High Similarity NPC207033
0.976 High Similarity NPC38823
0.7931 Intermediate Similarity NPC320064
0.7814 Intermediate Similarity NPC475962
0.768 Intermediate Similarity NPC210415
0.768 Intermediate Similarity NPC298851
0.768 Intermediate Similarity NPC181138
0.768 Intermediate Similarity NPC21752
0.768 Intermediate Similarity NPC276993
0.768 Intermediate Similarity NPC293255
0.7551 Intermediate Similarity NPC311357
0.75 Intermediate Similarity NPC129624
0.7416 Intermediate Similarity NPC153694
0.7416 Intermediate Similarity NPC211525
0.7363 Intermediate Similarity NPC278887
0.7308 Intermediate Similarity NPC470069
0.7308 Intermediate Similarity NPC52059
0.7295 Intermediate Similarity NPC174788
0.7286 Intermediate Similarity NPC474077
0.7278 Intermediate Similarity NPC310403
0.7278 Intermediate Similarity NPC97380
0.7278 Intermediate Similarity NPC148468
0.7278 Intermediate Similarity NPC63210
0.7278 Intermediate Similarity NPC263709
0.7278 Intermediate Similarity NPC243673
0.7228 Intermediate Similarity NPC469462
0.7216 Intermediate Similarity NPC28510
0.72 Intermediate Similarity NPC472100
0.7198 Intermediate Similarity NPC472121
0.7198 Intermediate Similarity NPC476114
0.7136 Intermediate Similarity NPC267414
0.7129 Intermediate Similarity NPC82070
0.7111 Intermediate Similarity NPC161827
0.7104 Intermediate Similarity NPC35510
0.7104 Intermediate Similarity NPC253667
0.7083 Intermediate Similarity NPC245741
0.7077 Intermediate Similarity NPC471196
0.7077 Intermediate Similarity NPC471195
0.7073 Intermediate Similarity NPC477548
0.7053 Intermediate Similarity NPC111732
0.7035 Intermediate Similarity NPC329024
0.7035 Intermediate Similarity NPC475559
0.7014 Intermediate Similarity NPC52254
0.701 Intermediate Similarity NPC282092
0.7 Intermediate Similarity NPC317672
0.6995 Remote Similarity NPC476115
0.698 Remote Similarity NPC32451
0.6978 Remote Similarity NPC477156
0.6978 Remote Similarity NPC477157
0.6976 Remote Similarity NPC474905
0.697 Remote Similarity NPC203972
0.6965 Remote Similarity NPC160127
0.6965 Remote Similarity NPC50997
0.6963 Remote Similarity NPC475271
0.6961 Remote Similarity NPC12944
0.6961 Remote Similarity NPC25442
0.6944 Remote Similarity NPC248903
0.6934 Remote Similarity NPC108826
0.6915 Remote Similarity NPC59033
0.6915 Remote Similarity NPC320748
0.6915 Remote Similarity NPC324245
0.6902 Remote Similarity NPC476194
0.6902 Remote Similarity NPC471203
0.6898 Remote Similarity NPC26928
0.6897 Remote Similarity NPC328559
0.6893 Remote Similarity NPC156044
0.6888 Remote Similarity NPC325775
0.6872 Remote Similarity NPC469460
0.6866 Remote Similarity NPC302548
0.6856 Remote Similarity NPC322043
0.6856 Remote Similarity NPC327373
0.6853 Remote Similarity NPC316405
0.6847 Remote Similarity NPC79223
0.6845 Remote Similarity NPC472106
0.6837 Remote Similarity NPC148124
0.6818 Remote Similarity NPC174629
0.681 Remote Similarity NPC292517
0.6806 Remote Similarity NPC473354
0.6802 Remote Similarity NPC57453
0.6802 Remote Similarity NPC328798
0.6798 Remote Similarity NPC472103
0.6791 Remote Similarity NPC99724
0.6788 Remote Similarity NPC126515
0.6788 Remote Similarity NPC472331
0.6788 Remote Similarity NPC274002
0.6778 Remote Similarity NPC254798
0.6772 Remote Similarity NPC470971
0.6771 Remote Similarity NPC50016
0.6769 Remote Similarity NPC325093
0.6769 Remote Similarity NPC477159
0.6768 Remote Similarity NPC182814
0.6765 Remote Similarity NPC259098
0.6765 Remote Similarity NPC197680
0.6761 Remote Similarity NPC162812
0.6754 Remote Similarity NPC307640
0.6754 Remote Similarity NPC273755
0.6753 Remote Similarity NPC39822
0.675 Remote Similarity NPC204970
0.6746 Remote Similarity NPC168250
0.6742 Remote Similarity NPC308197
0.674 Remote Similarity NPC242000
0.6738 Remote Similarity NPC471052
0.6738 Remote Similarity NPC472120
0.6738 Remote Similarity NPC472117
0.6738 Remote Similarity NPC471051
0.6738 Remote Similarity NPC472101
0.6738 Remote Similarity NPC471053
0.6737 Remote Similarity NPC469915
0.6735 Remote Similarity NPC471048
0.6735 Remote Similarity NPC294951
0.6735 Remote Similarity NPC471049
0.6735 Remote Similarity NPC471050
0.6732 Remote Similarity NPC472329
0.6732 Remote Similarity NPC472330
0.6724 Remote Similarity NPC472435
0.6721 Remote Similarity NPC184161
0.672 Remote Similarity NPC472114
0.672 Remote Similarity NPC472115
0.6714 Remote Similarity NPC30570
0.6709 Remote Similarity NPC472436
0.6704 Remote Similarity NPC49565
0.6703 Remote Similarity NPC10875
0.6703 Remote Similarity NPC10730
0.6702 Remote Similarity NPC313757
0.6701 Remote Similarity NPC45037
0.6701 Remote Similarity NPC318020
0.6701 Remote Similarity NPC49353
0.67 Remote Similarity NPC127647
0.67 Remote Similarity NPC472191
0.6698 Remote Similarity NPC326027
0.6684 Remote Similarity NPC474058
0.6684 Remote Similarity NPC477158
0.6683 Remote Similarity NPC20593
0.6683 Remote Similarity NPC309498
0.6682 Remote Similarity NPC106593
0.6667 Remote Similarity NPC4108
0.6667 Remote Similarity NPC262725
0.6667 Remote Similarity NPC140311
0.6651 Remote Similarity NPC473667
0.6649 Remote Similarity NPC40234
0.6649 Remote Similarity NPC85651
0.6649 Remote Similarity NPC257354
0.6649 Remote Similarity NPC473297
0.6635 Remote Similarity NPC14339
0.6633 Remote Similarity NPC473815
0.6633 Remote Similarity NPC476321
0.6632 Remote Similarity NPC279871
0.6632 Remote Similarity NPC473402
0.6632 Remote Similarity NPC13367
0.6632 Remote Similarity NPC476227
0.6632 Remote Similarity NPC294516
0.6632 Remote Similarity NPC471165
0.6632 Remote Similarity NPC19555
0.6632 Remote Similarity NPC477462
0.6632 Remote Similarity NPC107938
0.6631 Remote Similarity NPC291359
0.6616 Remote Similarity NPC472209
0.6615 Remote Similarity NPC269750
0.6615 Remote Similarity NPC194671
0.6615 Remote Similarity NPC230611
0.6607 Remote Similarity NPC170751
0.6604 Remote Similarity NPC326333
0.6599 Remote Similarity NPC471526
0.6594 Remote Similarity NPC472434
0.6588 Remote Similarity NPC477160
0.6587 Remote Similarity NPC246983
0.6587 Remote Similarity NPC475448
0.6576 Remote Similarity NPC473341
0.6575 Remote Similarity NPC237240
0.6575 Remote Similarity NPC31171
0.6573 Remote Similarity NPC244856
0.6569 Remote Similarity NPC108804
0.6569 Remote Similarity NPC476218
0.6567 Remote Similarity NPC163961
0.6567 Remote Similarity NPC22689
0.6567 Remote Similarity NPC105055
0.6567 Remote Similarity NPC473305
0.6562 Remote Similarity NPC475123
0.6562 Remote Similarity NPC475204
0.6561 Remote Similarity NPC133470
0.6561 Remote Similarity NPC476231
0.6561 Remote Similarity NPC289776
0.6561 Remote Similarity NPC191863
0.6555 Remote Similarity NPC268077
0.6546 Remote Similarity NPC155506
0.6546 Remote Similarity NPC159767
0.6546 Remote Similarity NPC26108
0.6544 Remote Similarity NPC37957
0.6543 Remote Similarity NPC471122
0.6538 Remote Similarity NPC475223
0.6537 Remote Similarity NPC144314
0.6535 Remote Similarity NPC99891
0.6531 Remote Similarity NPC475094
0.653 Remote Similarity NPC71539
0.653 Remote Similarity NPC250960
0.6526 Remote Similarity NPC292143
0.6526 Remote Similarity NPC139506
0.6526 Remote Similarity NPC189116
0.6524 Remote Similarity NPC473800

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC291759 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7017 Intermediate Similarity NPD8417 Discontinued
0.6919 Remote Similarity NPD2995 Approved
0.6833 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6802 Remote Similarity NPD4951 Discontinued
0.6794 Remote Similarity NPD4900 Clinical (unspecified phase)
0.6763 Remote Similarity NPD4901 Clinical (unspecified phase)
0.676 Remote Similarity NPD5595 Clinical (unspecified phase)
0.6703 Remote Similarity NPD3067 Approved
0.6683 Remote Similarity NPD6608 Clinical (unspecified phase)
0.6682 Remote Similarity NPD8326 Phase 3
0.6682 Remote Similarity NPD8325 Phase 3
0.6682 Remote Similarity NPD8327 Clinical (unspecified phase)
0.6633 Remote Similarity NPD8103 Clinical (unspecified phase)
0.6584 Remote Similarity NPD7570 Approved
0.6584 Remote Similarity NPD7569 Approved
0.6578 Remote Similarity NPD5715 Clinical (unspecified phase)
0.6575 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6571 Remote Similarity NPD7584 Approved
0.6569 Remote Similarity NPD5582 Discontinued
0.6556 Remote Similarity NPD4430 Phase 2
0.6534 Remote Similarity NPD2791 Discontinued
0.6528 Remote Similarity NPD3824 Phase 1
0.6508 Remote Similarity NPD7600 Phase 2
0.65 Remote Similarity NPD4168 Approved
0.6493 Remote Similarity NPD7583 Approved
0.6489 Remote Similarity NPD7735 Clinical (unspecified phase)
0.6473 Remote Similarity NPD7810 Phase 3
0.6473 Remote Similarity NPD7811 Phase 3
0.6473 Remote Similarity NPD6874 Approved
0.6462 Remote Similarity NPD7585 Approved
0.6455 Remote Similarity NPD7599 Phase 2
0.6436 Remote Similarity NPD6395 Phase 2
0.6436 Remote Similarity NPD6396 Clinical (unspecified phase)
0.6436 Remote Similarity NPD8025 Phase 2
0.6435 Remote Similarity NPD4897 Phase 2
0.6429 Remote Similarity NPD2575 Approved
0.6414 Remote Similarity NPD6879 Phase 2
0.6414 Remote Similarity NPD6878 Phase 2
0.6393 Remote Similarity NPD8323 Discontinued
0.6389 Remote Similarity NPD3605 Approved
0.6389 Remote Similarity NPD3068 Approved
0.6383 Remote Similarity NPD5741 Approved
0.6383 Remote Similarity NPD5743 Approved
0.6383 Remote Similarity NPD5742 Approved
0.6373 Remote Similarity NPD3785 Clinical (unspecified phase)
0.6373 Remote Similarity NPD5042 Phase 1
0.6364 Remote Similarity NPD5900 Clinical (unspecified phase)
0.6359 Remote Similarity NPD7256 Discontinued
0.6359 Remote Similarity NPD2216 Approved
0.6359 Remote Similarity NPD2215 Approved
0.6355 Remote Similarity NPD4334 Discontinued
0.6351 Remote Similarity NPD7064 Clinical (unspecified phase)
0.6346 Remote Similarity NPD7778 Approved
0.6346 Remote Similarity NPD53 Approved
0.6346 Remote Similarity NPD7777 Approved
0.6344 Remote Similarity NPD7613 Discontinued
0.6339 Remote Similarity NPD8059 Phase 3
0.6339 Remote Similarity NPD8058 Clinical (unspecified phase)
0.633 Remote Similarity NPD4121 Phase 3
0.633 Remote Similarity NPD4120 Approved
0.6327 Remote Similarity NPD8372 Clinical (unspecified phase)
0.6324 Remote Similarity NPD7441 Clinical (unspecified phase)
0.6319 Remote Similarity NPD2578 Phase 3
0.6316 Remote Similarity NPD7011 Discontinued
0.6313 Remote Similarity NPD5521 Clinical (unspecified phase)
0.631 Remote Similarity NPD3329 Clinical (unspecified phase)
0.6308 Remote Similarity NPD7795 Phase 2
0.6302 Remote Similarity NPD4871 Phase 2
0.6298 Remote Similarity NPD6206 Phase 1
0.6293 Remote Similarity NPD6058 Phase 2
0.6293 Remote Similarity NPD5077 Approved
0.6293 Remote Similarity NPD5076 Approved
0.6292 Remote Similarity NPD5121 Approved
0.6292 Remote Similarity NPD5119 Approved
0.6292 Remote Similarity NPD5120 Approved
0.6291 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6287 Remote Similarity NPD6557 Phase 2
0.6286 Remote Similarity NPD4500 Approved
0.6286 Remote Similarity NPD4501 Approved
0.6283 Remote Similarity NPD7589 Clinical (unspecified phase)
0.6283 Remote Similarity NPD4485 Approved
0.627 Remote Similarity NPD6609 Clinical (unspecified phase)
0.6268 Remote Similarity NPD6261 Phase 3
0.6264 Remote Similarity NPD3069 Approved
0.6262 Remote Similarity NPD8146 Phase 2
0.6261 Remote Similarity NPD8370 Discontinued
0.6261 Remote Similarity NPD5506 Approved
0.6261 Remote Similarity NPD5507 Approved
0.6256 Remote Similarity NPD7476 Discontinued
0.625 Remote Similarity NPD6063 Approved
0.625 Remote Similarity NPD6676 Phase 2
0.625 Remote Similarity NPD2996 Approved
0.6244 Remote Similarity NPD5997 Discontinued
0.6244 Remote Similarity NPD7629 Clinical (unspecified phase)
0.6244 Remote Similarity NPD7628 Phase 3
0.6244 Remote Similarity NPD7630 Phase 3
0.6238 Remote Similarity NPD6248 Phase 2
0.6238 Remote Similarity NPD6249 Phase 2
0.6235 Remote Similarity NPD2212 Approved
0.6235 Remote Similarity NPD2210 Approved
0.6231 Remote Similarity NPD6642 Approved
0.6231 Remote Similarity NPD8006 Clinical (unspecified phase)
0.6231 Remote Similarity NPD5334 Clinical (unspecified phase)
0.6231 Remote Similarity NPD6641 Approved
0.623 Remote Similarity NPD6886 Approved
0.623 Remote Similarity NPD6885 Approved
0.6228 Remote Similarity NPD7796 Approved
0.6228 Remote Similarity NPD7797 Approved
0.6222 Remote Similarity NPD7186 Phase 3
0.6216 Remote Similarity NPD3437 Discontinued
0.6213 Remote Similarity NPD8468 Phase 2
0.6212 Remote Similarity NPD7449 Clinical (unspecified phase)
0.6205 Remote Similarity NPD5823 Approved
0.6205 Remote Similarity NPD2904 Discontinued
0.6203 Remote Similarity NPD5881 Clinical (unspecified phase)
0.6203 Remote Similarity NPD4682 Phase 2
0.6196 Remote Similarity NPD6860 Clinical (unspecified phase)
0.6195 Remote Similarity NPD4086 Phase 1
0.6193 Remote Similarity NPD1165 Clinical (unspecified phase)
0.6188 Remote Similarity NPD7132 Clinical (unspecified phase)
0.6186 Remote Similarity NPD7263 Phase 2
0.6184 Remote Similarity NPD4941 Clinical (unspecified phase)
0.6184 Remote Similarity NPD4315 Phase 2
0.6181 Remote Similarity NPD8022 Clinical (unspecified phase)
0.6178 Remote Similarity NPD7821 Clinical (unspecified phase)
0.6175 Remote Similarity NPD4152 Approved
0.6171 Remote Similarity NPD2628 Approved
0.6171 Remote Similarity NPD2625 Approved
0.6171 Remote Similarity NPD2160 Approved
0.6171 Remote Similarity NPD2626 Approved
0.6171 Remote Similarity NPD2159 Approved
0.6171 Remote Similarity NPD2627 Approved
0.6165 Remote Similarity NPD2845 Phase 2
0.6165 Remote Similarity NPD3321 Discontinued
0.6165 Remote Similarity NPD2843 Phase 2
0.6162 Remote Similarity NPD6506 Clinical (unspecified phase)
0.6161 Remote Similarity NPD3800 Clinical (unspecified phase)
0.6158 Remote Similarity NPD5203 Approved
0.6158 Remote Similarity NPD4617 Approved
0.6158 Remote Similarity NPD2613 Approved
0.6158 Remote Similarity NPD4620 Approved
0.6158 Remote Similarity NPD5201 Approved
0.6154 Remote Similarity NPD5150 Phase 2
0.6154 Remote Similarity NPD6655 Clinical (unspecified phase)
0.6154 Remote Similarity NPD7036 Phase 3
0.6154 Remote Similarity NPD7591 Clinical (unspecified phase)
0.6154 Remote Similarity NPD7035 Approved
0.615 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6146 Remote Similarity NPD6793 Clinical (unspecified phase)
0.6146 Remote Similarity NPD3589 Clinical (unspecified phase)
0.6145 Remote Similarity NPD7086 Phase 2
0.6142 Remote Similarity NPD5186 Approved
0.6142 Remote Similarity NPD5183 Approved
0.6141 Remote Similarity NPD6681 Discovery
0.6141 Remote Similarity NPD6414 Clinical (unspecified phase)
0.6139 Remote Similarity NPD7149 Clinical (unspecified phase)
0.6138 Remote Similarity NPD3277 Phase 3
0.6137 Remote Similarity NPD7560 Approved
0.6135 Remote Similarity NPD3808 Clinical (unspecified phase)
0.6133 Remote Similarity NPD3912 Discontinued
0.6133 Remote Similarity NPD7820 Phase 3
0.6127 Remote Similarity NPD6021 Clinical (unspecified phase)
0.6124 Remote Similarity NPD4274 Approved
0.6124 Remote Similarity NPD4275 Approved
0.6124 Remote Similarity NPD3720 Discontinued
0.6121 Remote Similarity NPD3802 Phase 3
0.6121 Remote Similarity NPD5487 Phase 1
0.6121 Remote Similarity NPD7205 Discontinued
0.6121 Remote Similarity NPD6669 Phase 2
0.6116 Remote Similarity NPD7805 Phase 3
0.6116 Remote Similarity NPD8461 Discontinued
0.6114 Remote Similarity NPD6060 Clinical (unspecified phase)
0.6114 Remote Similarity NPD7114 Clinical (unspecified phase)
0.6114 Remote Similarity NPD5856 Discontinued
0.6114 Remote Similarity NPD3125 Approved
0.6111 Remote Similarity NPD5185 Approved
0.6111 Remote Similarity NPD6310 Approved
0.6111 Remote Similarity NPD6309 Approved
0.6111 Remote Similarity NPD5184 Approved
0.6111 Remote Similarity NPD2388 Discontinued
0.6111 Remote Similarity NPD5182 Approved
0.6111 Remote Similarity NPD6311 Approved
0.6111 Remote Similarity NPD7043 Discontinued
0.6108 Remote Similarity NPD5596 Phase 2
0.6106 Remote Similarity NPD5214 Phase 2
0.6101 Remote Similarity NPD4997 Clinical (unspecified phase)
0.6099 Remote Similarity NPD3864 Clinical (unspecified phase)
0.6098 Remote Similarity NPD5444 Phase 1
0.6098 Remote Similarity NPD3153 Approved
0.6098 Remote Similarity NPD3154 Approved
0.6094 Remote Similarity NPD6913 Approved
0.6094 Remote Similarity NPD1663 Discontinued
0.6094 Remote Similarity NPD7118 Clinical (unspecified phase)
0.6093 Remote Similarity NPD7891 Discontinued
0.6093 Remote Similarity NPD5102 Clinical (unspecified phase)
0.6093 Remote Similarity NPD7396 Approved
0.6091 Remote Similarity NPD7890 Discontinued
0.6091 Remote Similarity NPD4986 Clinical (unspecified phase)
0.6089 Remote Similarity NPD6654 Clinical (unspecified phase)
0.6087 Remote Similarity NPD8361 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data